Monopar Therapeutics (MNPR) EPS (Basic) (2017 - 2026)
Monopar Therapeutics (MNPR) posted EPS (Basic) of -$0.6 for Q3 2025, down 62.72% sequentially from -$0.37 in Q2 2025, and down 42.99% YoY from -$1.05 in Q3 2024.
Monopar Therapeutics (MNPR) EPS (Basic) (2017 - 2026) Analysis & Trends
Monopar Therapeutics has reported EPS (Basic) for 9 years, with the latest figure at -$0.6 in Q3 2025.
- Quarterly EPS (Basic) fell 42.99% year-over-year to -$0.6 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$1.36 (down 3.69% YoY) and the FY2025 annual result came in at -$1.85, up 54.72% from the prior year.
- EPS (Basic) declined to -$0.6 in Q3 2025 per MNPR's latest filing, from -$0.37 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.37 in Q2 2025 and troughed at -$5.28 in Q4 2022.
- A 5-year average of -$1.21 and a median of -$0.83 in 2021 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2021 and 2024: EPS (Basic) tumbled 45.75% in 2021, then surged 43.9% in 2024.
- Over 5 years, EPS (Basic) stood at -$4.17 in 2021, then decreased by 26.53% to -$5.28 in 2022, then surged by 86.89% to -$0.69 in 2023, then surged by 39.42% to -$0.42 in 2024, then slumped by 42.99% to -$0.6 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.6, -$0.37, and -$0.46 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Monopar Therapeutics | 965.64 Mn | 912.88 Mn | - | -0.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.75 |
| Sep 30, 2025 | -0.60 |
| Jun 30, 2025 | -0.37 |
| Mar 31, 2025 | -0.46 |
| Sep 30, 2024 | -0.42 |
| Jun 30, 2024 | -0.51 |
| Mar 31, 2024 | -0.53 |
| Sep 30, 2023 | -0.69 |
| Jun 30, 2023 | -0.87 |
| Mar 31, 2023 | -0.95 |
| Dec 31, 2022 | -5.28 |
| Sep 30, 2022 | -0.95 |
| Jun 30, 2022 | -1.13 |
| Mar 31, 2022 | -0.98 |
| Dec 31, 2021 | -4.17 |
| Sep 30, 2021 | -0.98 |
| Jun 30, 2021 | -0.83 |
| Mar 31, 2021 | -0.78 |
| Dec 31, 2020 | -3.41 |
| Sep 30, 2020 | -0.74 |